Articles

BST02 is a novel cell-based immunotherapy currently being evaluated in a Phase I trial for the treatment of all types of liver cancer.

FDA Grants Fast Track Designation to Tumor-Infiltrating Lymphocyte Therapy for Liver Cancer

Health Affairs study investigates the consequences of patient medication abandonment surrounding oral HIV pre-exposure prophylaxis.

Forecasting the Effect of Out-of-Pocket Cost Changes for HIV Medication

In order to provide both profitability and medication access, a balancing act is required.

A Pharma Pricing and Agreements Primer in Today's Complex Landscape

Duplicate rebates have resulted in revenue leakage for manufacturers.

The Impact of 340B on Commercial Contracts

DELFI-TF assay shows promise in evaluating treatment response and resistance to immunotherapies in patients with advanced cancers.

Newly Launched Assay May Improve Monitoring of Cancer Treatment Response

Rusfertide could potentially be a first-in-class, transformational treatment for polycythemia vera.

Takeda Announces Partnership With Protagonist to Develop Novel Polycythemia Vera Drug

Vabysmo, the first bispecific antibody approved by the FDA for ocular conditions, produced significant drying of retinal fluid, which is often associated with blurry vision.

Vabysmo Shows Efficacy Improving Vision, Reducing Dryness in Retinal Vein Occlusion 

Per the deal, the company establishes Regeneron Cell Medicines, while also providing it with access to the collection’s full development and commercialization rights.

Regeneron Acquires 2seventy bio’s Novel Immune Cell Therapy Pipeline 

Biogen and partner Eisai will shift focus to advancing Leqembi, the first anti-amyloid beta treatment for Alzheimer disease to be granted traditional approval by the FDA.

Biogen Discontinues Maligned Alzheimer Disease Treatment Aduhelm  

Under the DSCSA law, wholesale distributors, re-packagers, dispensers, and other third-party logistics providers must implement interoperable and electronic tracing of prescription products at the package level.

News